{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:24:50Z","timestamp":1784841890430,"version":"3.55.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNRD"],"DOI":"10.2147\/ijnrd.s41626","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T23:57:55Z","timestamp":1399593475000},"page":"161","source":"Crossref","is-referenced-by-count":10,"title":["Clinical and economic aspects of sevelamer therapy in end-stage renal disease patients"],"prefix":"10.2147","author":[{"given":"Shahrzad","family":"Ossareh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,5]]},"container-title":["International Journal of Nephrology and Renovascular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=19959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:23:13Z","timestamp":1477866193000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/clinical-and-economic-aspects-of-sevelamer-therapy-in-end-stage-renal--peer-reviewed-article-IJNRD"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ijnrd.s41626","relation":{},"ISSN":["1178-7058"],"issn-type":[{"value":"1178-7058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}